Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cytomegalovirus Laryngitis in Primary Combined Immunodeficiency Diseases.
Inoue M, Isoda T, Yamashita M, Tomoda T, Inoue K, Okano T, Ohkawa T, Endo A, Mitsuiki N, Kamiya T, Yanagimachi M, Yamamoto K, Inaba Y, Sasaki T, Takagi M, Kanegane H, Imai K, Morio T. Inoue M, et al. Among authors: yamamoto k. J Clin Immunol. 2021 Jan;41(1):243-247. doi: 10.1007/s10875-020-00873-9. Epub 2020 Oct 8. J Clin Immunol. 2021. PMID: 33033934 No abstract available.
Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer.
Tamura K, Tomita Y, Kanazawa T, Shinohara H, Sakano M, Ishibashi S, Ikeda M, Kinoshita M, Minami J, Yamamoto K, Kato Y, Furukawa A, Haruki S, Tokunaga M, Kinugasa Y, Kurata M, Kitagawa M, Ohashi K, Yamamoto K. Tamura K, et al. Among authors: yamamoto k. Int J Mol Sci. 2024 Aug 24;25(17):9203. doi: 10.3390/ijms25179203. Int J Mol Sci. 2024. PMID: 39273151 Free PMC article.
GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies.
Takahara H, Kanazawa T, Oshita H, Tomita Y, Hananoi Y, Ishibashi S, Ikeda M, Furukawa A, Kinoshita M, Yamamoto K, Kato Y, Ishibashi H, Okubo K, Kurata M, Kitagawa M, Ohashi K, Yamamoto K. Takahara H, et al. Among authors: yamamoto k. Cancers (Basel). 2024 Nov 20;16(22):3888. doi: 10.3390/cancers16223888. Cancers (Basel). 2024. PMID: 39594843 Free PMC article.
Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast Cancer.
Shinohara H, Kobayashi M, Hayashi K, Nogawa D, Asakawa A, Ohata Y, Kubota K, Takahashi H, Yamada M, Tokunaga M, Kinugasa Y, Oda G, Nakagawa T, Onishi I, Kinowaki Y, Kurata M, Ohashi K, Kitagawa M, Yamamoto K. Shinohara H, et al. Among authors: yamamoto k. Int J Mol Sci. 2022 Oct 31;23(21):13235. doi: 10.3390/ijms232113235. Int J Mol Sci. 2022. PMID: 36362023 Free PMC article.
Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell Lymphoma.
Kawade G, Kurata M, Matsuki Y, Fukuda S, Onishi I, Kinowaki Y, Watabe S, Ishibashi S, Ikeda M, Yamamoto M, Ohashi K, Kitagawa M, Yamamoto K. Kawade G, et al. Among authors: yamamoto m, yamamoto k. Lab Invest. 2024 Apr;104(4):102027. doi: 10.1016/j.labinv.2024.102027. Epub 2024 Feb 3. Lab Invest. 2024. PMID: 38311062
The Comprehensive Characterization of B7-H3 Expression in the Tumor Microenvironment of Lung Squamous Cell Carcinoma: A Retrospective Study.
Asakawa A, Yoshimoto R, Kobayashi M, Izumi N, Maejima T, Deguchi T, Kubota K, Takahashi H, Yamada M, Ishibashi S, Onishi I, Kinowaki Y, Kurata M, Kobayashi M, Ishibashi H, Okubo K, Ohashi K, Kitagawa M, Yamamoto K. Asakawa A, et al. Among authors: yamamoto k. Cancers (Basel). 2024 Jun 4;16(11):2140. doi: 10.3390/cancers16112140. Cancers (Basel). 2024. PMID: 38893259 Free PMC article.
15,601 results
You have reached the last available page of results. Please see the User Guide for more information.